NCT00081926View on ClinicalTrials.gov

Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

March 31, 2007

Conditions
Chronic Myelogenous Leukemia
Interventions
DRUG

Gleevec

Trial Locations (1)

Unknown

Novartis RIGHT Trial Hotline, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY